Lymph node dissection in gastrectomy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Gastric cancer was diagnosed by gastroscopy and pathological biopsy; 2. complete TNM stage; 3. clinical stage was T2-4N0-3M0; 4. ECOG <=2 and D2 lymph node dissection is tolerated; 5. Be able to follow protocol during study period and sign informed consent; 6. No history of gastrointestinal surgery, chemotherapy or radiotherapy.
Exclusion criteria
Exclusion criteria: 1. Patients having contraindications for gastroscopy; 2. Patients having such surgical contraindications as coagulation disorders or cardiopulmonary insufficiency, or patients requiring for immunosuppressive therapy because of uncontrollable epilepsy, central nervous system diseases, history of mental disturbance or organ transplantation; 3. Patients who failed to receive standard D2 radical gastrectomy for gastric cancer; 4. Patients who were pregnant or breastfeeding, patients with childbearing potential yet not taking any effective contraceptives and patients planning to conceive; 5. Patients complicated by malignancies of other body systems, or proven to have metastatic gastric or non-gastric cancer during surgical operations; 6. Patients participating in other clinical trials at the same period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lymph node metastasis ; | — |
Countries
China
Contacts
Beijing Friendship Hospital Affiliated to Capital Medical University